Display options
Share it on

Heliyon. 2020 Aug;6(8):e04696. doi: 10.1016/j.heliyon.2020.e04696. Epub 2020 Aug 20.

Leptin levels in SARS-CoV-2 infection related respiratory failure: A cross-sectional study and a pathophysiological framework on the role of fat tissue.

Heliyon

Peter H J van der Voort, Jill Moser, Durk F Zandstra, Anneke C Muller Kobold, Marjolein Knoester, Cornelis F Calkhoven, Inge Hamming, Matijs van Meurs

Affiliations

  1. Department of Critical Care, University of Groningen, University Medical Center Groningen, 9700, RB, Groningen, the Netherlands.
  2. Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, 9700, RB, Groningen, the Netherlands.
  3. Department of Clinical Microbiology and Infection Prevention, University of Groningen, University Medical Center Groningen, 9700, RB, Groningen, the Netherlands.
  4. European Research Institute for the Biology of Ageing (ERIBA), University Medical Center Groningen, University of Groningen, 9700, AD, Groningen, the Netherlands.

PMID: 32844126 PMCID: PMC7439829 DOI: 10.1016/j.heliyon.2020.e04696

Abstract

Obesity is a risk factor for SARS-CoV-2 infected patients to develop respiratory failure. Leptin produced in visceral fat might play a role in the deterioration to mechanical ventilation. A cross sectional study was performed. The mean BMI was 31 kg/m

© 2020 The Author(s).

Keywords: ACE2; ARDS; COVID-19; Critical care; Fat; Intensive care medicine; Leptin; Microbiology; Respiratory system; SARS-CoV-2; Virology

References

  1. Lung. 2020 Apr;198(2):323-331 - PubMed
  2. Front Cell Infect Microbiol. 2018 May 09;8:147 - PubMed
  3. Nutrition. 2011 Mar;27(3):269-75 - PubMed
  4. Nat Rev Endocrinol. 2020 Jul;16(7):341-342 - PubMed
  5. JAMA. 2020 Mar 17;323(11):1061-1069 - PubMed
  6. JCI Insight. 2016 Jun 2;1(8): - PubMed
  7. Int J Obes Relat Metab Disord. 1999 Jan;23(1):75-82 - PubMed
  8. Am J Physiol Endocrinol Metab. 2020 May 1;318(5):E736-E741 - PubMed
  9. Int J Infect Dis. 2016 Aug;49:129-33 - PubMed
  10. Eur J Clin Invest. 2009 Oct;39(10):899-905 - PubMed
  11. Nat Rev Immunol. 2011 Feb;11(2):85-97 - PubMed
  12. J Neurophysiol. 2009 Jun;101(6):2898-906 - PubMed
  13. Curr Pharm Des. 2014;20(4):635-40 - PubMed
  14. N Engl J Med. 2020 May 21;382(21):2012-2022 - PubMed
  15. Reprod Toxicol. 2014 Nov;49:155-61 - PubMed
  16. Front Immunol. 2019 May 10;10:1071 - PubMed
  17. Science. 2002 Jul 12;297(5579):240-3 - PubMed
  18. J Adv Res. 2020 Mar 16;24:91-98 - PubMed
  19. Kidney Int. 2011 Jan;79(2):162-8 - PubMed
  20. PLoS One. 2017 Jun 7;12(6):e0178769 - PubMed
  21. Physiol Res. 2001;50(6):589-94 - PubMed
  22. J Pathol. 2004 Jun;203(2):631-7 - PubMed
  23. Rhinology. 2020 Jun 1;58(3):299-301 - PubMed
  24. Lancet Respir Med. 2020 Mar;8(3):e11-e12 - PubMed
  25. Clin Infect Dis. 2011 Sep;53(5):413-21 - PubMed
  26. FASEB J. 1999 Jul;13(10):1231-8 - PubMed
  27. Am J Respir Crit Care Med. 2007 Mar 15;175(6):587-94 - PubMed
  28. Lancet Respir Med. 2020 May;8(5):475-481 - PubMed

Publication Types